泓博医药 (301230.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(泓博医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 30.0039.0036.0039.0033.0039.0036.00
 单季度销售净利率(%) 10.0015.0013.0020.0014.0010.0010.00
 单季度净资产收益率ROE(%) 1.002.001.004.005.003.003.00
 单季度总资产净利率ROA(%) 1.001.001.003.003.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 129,557,463.00116,262,613.00121,392,447.00146,754,883.00126,261,736.00101,552,674.00104,314,491.00
 单季度营业总成本(元) 119,059,486.0095,824,070.00104,504,261.00118,668,917.00108,584,166.0089,693,559.0092,457,818.00
 单季度营业收入(元) 129,557,463.00116,262,613.00121,392,447.00146,754,883.00126,261,736.00101,552,674.00104,314,491.00
 单季度营业利润(元) 12,723,651.0019,403,181.0017,368,077.0030,826,758.0018,745,085.0011,631,472.0011,641,964.00
 单季度利润总额(元) 12,501,213.0019,261,220.0017,237,208.0030,771,211.0018,850,313.0011,598,442.0011,701,557.00
 单季度净利润(元) 13,045,825.0017,612,396.0015,275,796.0029,002,601.0017,651,862.0010,131,769.0010,389,651.00
 单季度归属母公司股东的净利润(元) 13,045,825.0017,612,396.0015,275,796.0029,002,601.0017,651,862.0010,131,769.0010,389,651.00
 单季度经营活动产生的现金流量(元) 16,621,169.0022,545,061.0013,556,647.0028,103,752.0027,954,729.0015,634,828.0027,600,828.00
 单季度投资活动产生的现金流量(元) -42,431,319.00-189,119,224.00-425,843,103.00-22,146,499.00-48,669,716.00-44,767,508.00-16,223,338.00
 单季度筹资活动产生的现金流量(元) -7,081,487.00-31,978,420.00-4,653,403.00695,616,991.00-162,036.00-6,863,055.00-5,969,655.00
 单季度现金及现金等价物净增加(元) -32,609,455.00-196,137,673.00-418,568,831.00701,564,979.00-19,010,028.00-29,222,686.004,558,470.00

前瞻产业研究院